Challenges in prescribing DOACs for stroke prevention in AF - PACE-CME

Challenges in prescribing DOACs for stroke prevention in AF

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Continuation or interruption of OAC during TAVI?
Continuation or interruption of OAC during TAVI?
ESC Congress 2024
Continuation or interruption of OAC during TAVI?
- Dirk Jan van Ginkel, MD
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
ESC Congress 2024
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
- Manesh R. Patel, MD, FACC, FAHA, FSCAI
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
ESC Congress 2024
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
- Isabelle van Gelder, MD, PhD
Unexpected results after switching from VKA to DOAC in frail older patients with AF
Unexpected results after switching from VKA to DOAC in frail older patients with AF
ESC Congress 2023
Unexpected results after switching from VKA to DOAC in frail older patients with AF
- Linda Joosten, MD